The Mark Foundation For Cancer Research Us Ltd
- Assets
- $104.5m
- Revenue
- $40.9m
- Investments
- $14.9m
- Employees
- 11
- Location
- New York, NY
- Founding
- 08/2016
- Data as of
- 12/2023
- EIN
- 36-4825921
Organization Overview
The Mark Foundation For Cancer Research Us Ltd is located in New York, NY. The organization was established in 2016. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Mark Foundation For Cancer Research Us Ltd employed 11 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Mark Foundation For Cancer Research Us Ltd is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Mark Foundation For Cancer Research Us Ltd generated $40.9m in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 73.4% each year . All expenses for the organization totaled $35.2m during the year ending 12/2023. While expenses have increased by 82.1% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Mark Foundation For Cancer Research Us Ltd has awarded 197 individual grants totaling $148,490,842. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ACCELERATE RESEARCH TO TRANSFORM PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE FOUNDATION'S GRANTS REWARD INNOVATIVE THINKING THAT ADVANCES THE UNDERSTANDING OF CANCER BIOLOGY AND IMPROVES ONCOLOGY TREATMENT PARADIGMS. THE FOUNDATION SUPPORTS INDIVIDUAL INVESTIGATORS, AS WELL AS MULTIDISCIPLINARY COLLABORATIVE TEAMS CONDUCTING RESEARCH ACROSS CANCER TYPES. THE GRANTEES BECOME PART OF THE FOUNDATION'S NETWORK OF THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TECHNOLOGICAL INNOVATION. GRANT SUBMISSIONS UNDERGO RIGOROUS PEER REVIEW BY THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE OR RECOMMENDED SUBJECT MATTER EXPERTS AND ARE HELD TO THE STRICTEST STANDARDS OF SCIENTIFIC EXCELLENCE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Alex Knaster As Of 423 Director | Trustee | 1 | $0 |
Ross Levine Director | Trustee | 1 | $10,000 |
Nicola Mendehlson As Of 523 Director | Trustee | 1 | $0 |
Paul Pospisil Director | Trustee | 1 | $0 |
Otmar D Wiestler As Of 52023 Director | Trustee | 1 | $0 |
Raymond Dubois Executive Chairman Of The Board | OfficerTrustee | 24 | $560,000 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
The Appointment Group Travel/event Consult | 12/30/23 | $395,426 |
Arnold & Porter Kaye Scholer Llp Legal Services | 12/30/23 | $166,874 |
Your Part Time Controller Accounting | 12/30/23 | $157,018 |
Wipfli Crm Consulting | 12/30/23 | $149,136 |
Lgh Communications Communications | 12/30/23 | $106,345 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $39,897,754 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $39,897,754 |
| Total Program Service Revenue | $0 |
| Investment income | $1,035,039 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$4,901 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $40,937,632 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $24,556,055 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $5,269,698 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,828,563 |
| Compensation of current officers, directors, key employees. | $320,641 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,007,884 |
| Pension plan accruals and contributions | $20,658 |
| Other employee benefits | $152,865 |
| Payroll taxes | $124,053 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $238,259 |
| Fees for services: Accounting | $228,212 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $134,902 |
| Advertising and promotion | $0 |
| Office expenses | $17,238 |
| Information technology | $67,786 |
| Royalties | $0 |
| Occupancy | $410,442 |
| Travel | $243,830 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $502,777 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $91,069 |
| Insurance | $29,309 |
| All other expenses | $179,260 |
| Total functional expenses | $35,209,497 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $3,483,399 |
| Savings and temporary cash investments | $18,877,966 |
| Pledges and grants receivable | $62,373,066 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $3,029,739 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $136,382 |
| Net Land, buildings, and equipment | $95,170 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $14,916,600 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,580,066 |
| Total assets | $104,492,388 |
| Accounts payable and accrued expenses | $625,207 |
| Grants payable | $18,102,751 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,287,461 |
| Total liabilities | $20,015,419 |
| Net assets without donor restrictions | $80,853,903 |
| Net assets with donor restrictions | $3,623,066 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $104,492,388 |
Grants Awarded
Over the last fiscal year, The Mark Foundation For Cancer Research Us Ltd has awarded $24,414,174 in support to 36 organizations.
| Grant Recipient | Amount |
|---|---|
BAYLOR COLLEGE OF MEDICINE PURPOSE: RESEARCH | $246,366 |
CHILDREN'S NATIONAL MEDICAL CENTER PURPOSE: RESEARCH | $127,500 |
BRIGHAM AND WOMEN'S HOSPITAL INC PURPOSE: RESEARCH | $375,000 |
DANA FARBER CANCER INSTITUTE INC PURPOSE: RESEARCH | $3,362,500 |
GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH PURPOSE: RESEARCH | $666,666 |
DAMON RUNYON WALTER WINCHELL FOUNDATION PURPOSE: RESEARCH | $306,316 |